pipette
ENEnglish

PARG inhibition elicits cytotoxicity by sequestering XRCC1 and other PAR-binding proteins into PAR-dependent nuclear condensates

Isaac Dumoulin, Brian J. Lee, Chuhan Zhang, Xiaohui Lin, Yunyue Wang, Richard P. Han, Priyanka Verma, Shan Zha

Revista con revisión por pares

En palabras de los autores

DNA breaks activate PARP1/2 to synthesize poly(ADP-ribose) (PAR), which relax chromatin and recruit DNA repair factors. PAR is normally short-lived and rapidly degraded by poly(ADP-ribose) glycohydrolase (PARG). While PARP1/2 inhibitors target homologous recombination (HR)-deficient cancers, predictive biomarkers for PARG inhibition (PARGi) remain undefined. Using genome-wide CRISPR screens, we find that PARGi is synthetically lethal with loss of multiple PAR-binding factors (XRCC1-LIG3/POLB, ALC1/CHD1L, ARH3, PARG itself) but not HR-deficiency. Conversely, loss of PARP1, NMNAT1 (nuclear NAD⁺ synthesis), or UNG confers resistance. Mechanistically, PARGi induces reversible PARP1- and PAR-dependent nuclear condensates in undamaged cells. While lacking detectable DNA breaks, these condensates sequester various PAR-binding proteins (e.g. XRCC1, ALC1, FUS), reducing their nuclear availability and impairing recruitment to bona fide DNA lesions. These findings identify PAR-binding protein sequestration as the mechanism underlying PARGi cytotoxicity, explain the paradoxical essentiality of PARG but not PARP1, and establish PAR-binding factor deficiency as a biomarker for PARGi. While PARP inhibitors are well characterized, predictive biomarkers for PARG inhibition are undefined. Here, the authors propose a unified mechanism in which the sequestration of PAR-binding proteins underlies PARG inhibitor-induced cytotoxicity.

Resultado principalEl resumen no menciona limitaciones.

Apareció: viernes, 23 de octubre. Nature Communications. Revista con revisión por pares.

DOI: 10.1038/s41467-026-78665-9